Advertisement
Advertisement

Iterum Therapeutics sees FY26 ORLYNVAH net product sales $5M-$15M

07:07 EST Iterum Therapeutics (ITRM) sees FY26 ORLYNVAH net product sales $5M-$15M

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1